Emergent BioSolutions adjusts executive pay after falling short of 2022 goals


The Gaithersburg biotech is among a few local companies that have restructured and initiated layoffs. Here's what's next.

Previous $45M Virtua-Penn Medicine proton therapy center treats its first patient
Next MGH doctor, Harvard teacher and CDC advisor will head the Department of Public Health